Expert opinion on NSCLC small specimen biomarker testing — Part 2: Analysis, reporting, and quality assessment

The diagnostic work-up for non-small cell lung cancer (NSCLC) requires biomarker testing to guide therapy choices. This article is the second of a two-part series. In Part 1, we summarised evidence-based recommendations for obtaining and processing small specimen samples (i.e. pre-analytical steps)...

Descripción completa

Detalles Bibliográficos
Autores principales: Penault-Llorca, Frédérique, Kerr, Keith M., Garrido, Pilar, Thunnissen, Erik, Dequeker, Elisabeth, Normanno, Nicola, Patton, Simon J., Fairley, Jenni, Kapp, Joshua, de Ridder, Daniëlle, Ryška, Aleš, Moch, Holger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review and Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297263/
https://www.ncbi.nlm.nih.gov/pubmed/35857103
http://dx.doi.org/10.1007/s00428-022-03344-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297263/
https://www.ncbi.nlm.nih.gov/pubmed/35857103
http://dx.doi.org/10.1007/s00428-022-03344-1

Ejemplares similares